Badminton and Eczema-Prone Skin: Hand Care Between Matches
Dr. Arsy Editorial Team · October 25, 2026 · Sports & eczema-prone skin
Badminton gives the hands two very different jobs: hold a racket securely during a rally and recover comfortably afterward. Eczema-prone skin can make the transition between those jobs feel complicated. Keep the plan focused. Notice where irritation occurs, have your personal clean-up supplies ready and choose an off-court time for a moisturizer, so you can evaluate it without compromising your grip.
Check the pattern around the racket handle
If discomfort follows a new grip or overgrip, note when it appeared and where it sits. Bring the product details to a clinician if a rash recurs. The AAD describes contact dermatitis as a reaction to substances touching skin. [1] That possibility is one reason not to assume a recurring hand rash only needs more moisturizer.
Avoid changing a grip, cleanser and moisturizer together immediately before a tournament. One change at a time is an organizational choice that makes your observations easier to interpret. It does not replace allergy testing or medical assessment.
| When | Focus | Practical step |
|---|---|---|
| Before your session | Check hands and equipment changes | Record a new grip or a recurring contact pattern. |
| Between matches | Use your own clean towel | Avoid turning a product trial into an in-match experiment. |
| After washing | Apply your familiar moisturizer as directed | Use clean hands and close the personal jar. |
| Before the next rally | Check grip security | Keep palms free of residue that changes racket handling. |
Choose the quiet period after play for moisture care
Have clean hands before opening your jar, and keep it away from the towel used for the court or equipment. Use #003 as its label directs after your normal washing routine. Let your hands return to a secure, residue-free grip before handling the racket again.
The AAD suggests trying a new skin-care product on a small area for 7–10 days. [2] Build that trial into an ordinary training week rather than relying on a first application between important matches. Even a fragrance-free product may not suit every individual.
What hydration data can tell a badminton player
Dr. Arsy #003 is an ultra-rich cream for cosmetic moisture care of the face, hands and body. The current formula includes glycerin, panthenol, squalane and shea butter. Its whole-formula clinical results are more specific than a general ingredient story.
The study measured hydration with a corneometer and water loss with a Tewameter. It did not measure racket slippage, grip endurance, sweat resistance or a reduction in hand eczema. Read the percentages as objective moisturizing results, not as an athletic performance claim.
Clinical results: hydration and moisture-barrier support
An average hydration increase does not predict an individual player's exact response. It offers evidence for the tested cream's moisture role while leaving personal tolerance and grip safety to be assessed separately.
In a Dr. Arsy-sponsored study conducted by SkinScience Analytics, 31 healthy women aged 22–70 completed testing of Moisturizer #003. Average skin hydration increased 55.46% at 30 minutes and remained 37.19% above baseline at eight hours. The product outperformed the untreated site for hydration at both time points (reported p ≤ 0.001). [S1]
| Measurement | Time | #003 | Untreated site |
|---|---|---|---|
| Skin hydration | 30 minutes | +55.46% | +6.04% |
| Skin hydration | 8 hours | +37.19% | +2.78% |
| Water loss (TEWL) | 30 minutes | −63.59% | −55.10% |
| Water loss (TEWL) | 8 hours | −61.50% | −52.75% |
How to read the table: Hydration changes use the pretreatment baseline. TEWL changes use the baseline after controlled tape stripping, which temporarily disrupted the barrier. Lower TEWL means less water escaping through skin. Untreated skin also recovered; the additional reduction with #003 was 8.49 percentage points at 30 minutes (p = 0.029) and 8.74 points at eight hours (p = 0.006).
The findings support the tested cream's cosmetic hydration and moisture-barrier benefits. They do not establish improvement in eczema severity, fewer flares, or protection during exercise. This was a small, short-term, sponsor-funded study in healthy adults, not an athlete or eczema-treatment trial. Individual results can differ.
A simple place for #003 in your routine
Choose a repeatable moment after your usual clean-up for moisture care. Dr. Arsy Hydration Recovery Moisturizer #003, 4 oz (120 g) is a fragrance-free, ultra-rich cream for face, hands and body. Follow the current package directions and your clinician's instructions for any prescribed treatments. It is a cosmetic moisturizer, not an eczema medicine.
Common questions
Should I apply a thick layer right before a match?
Do not use an amount or timing that compromises grip. The study provides no pre-match badminton application protocol.
Does fragrance-free guarantee my hands will tolerate it?
No. Check the full ingredient list and individual tolerance; seek advice for a persistent rash.
Sources and clinical reference
- American Academy of Dermatology — Contact dermatitis: causes.
- American Academy of Dermatology — Atopic dermatitis skin care.
- British Association of Dermatologists — Contact dermatitis patient information.
S1 — Product-specific clinical source: SkinScience Analytics. A Clinical Evaluation of the Efficacy of a Skincare Product in Improving Skin Hydration and Skin Barrier Repair. Final Report SSA 25-058, July 8, 2025; test article Moisturizer #003, UIN 2110; pages 4–6 and study protocol. Sponsor: Dr. Arsy Skincare. Original report supplied by the brand and held on file. See The Science for brand research information. External sources provide general guidance and do not endorse #003 or substantiate its product-specific numbers.
Sources checked October 25, 2026. Sport-specific routines are editorial applications of general guidance, not validated treatment protocols. Hero image: AI-generated editorial illustration using the brand's jar reference; pictured athletes are not clinical-study participants or endorsers.